Viruses 2010, 2(3), 731-747; doi:10.3390/v2030731
Article

A Novel System for Identification of Inhibitors of Rift Valley Fever Virus Replication

1 Cellular and Molecular Biology Program, University of Michigan, Ann Arbor, MI, USA 2 Department of Epidemiology, University of Michigan, Ann Arbor, MI, USA
* Author to whom correspondence should be addressed.
Received: 11 December 2009; in revised form: 7 March 2010 / Accepted: 9 March 2010 / Published: 18 March 2010
PDF Full-text Download PDF Full-Text [1346 KB, uploaded 18 March 2010 12:11 CET]
Abstract: Rift Valley fever virus (RVFV) is a human and livestock pathogen endemic to sub-Saharan Africa. We have developed a T7-dependent system for the efficient production of RVFV-like particles (RVF-VLPs) based on the virulent ZH-501 strain of RVFV. The RVF-VLPs are capable of performing a single round of infection, allowing for the study of viral replication, assembly, and infectivity. We demonstrate that these RVF-VLPs are antigenically indistinguishable from authentic RVFV and respond similarly to a wide array of known and previously unknown chemical inhibitors. This system should be useful for screening for small molecule inhibitors of RVFV replication.
Keywords: Rift Valley fever; virus-like particle; RNA virus; Bunyaviridae; Phlebovirus; minigenome; antivirals

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Piper, M.E.; Gerrard, S.R. A Novel System for Identification of Inhibitors of Rift Valley Fever Virus Replication. Viruses 2010, 2, 731-747.

AMA Style

Piper ME, Gerrard SR. A Novel System for Identification of Inhibitors of Rift Valley Fever Virus Replication. Viruses. 2010; 2(3):731-747.

Chicago/Turabian Style

Piper, Mary E.; Gerrard, Sonja R. 2010. "A Novel System for Identification of Inhibitors of Rift Valley Fever Virus Replication." Viruses 2, no. 3: 731-747.

Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert